Calls the trim the boldest trade on the desk: price is at the decision zone below the 10 EMA and VWMA, the golden cross is a 92-session-late rearview signal, and the 28%/8% prediction-market skew toward $640 versus $860 is real money, not a poll.
Wants the full ~50% cut executed now at $716–719 rather than waiting for $713 to break and competing to sell at $700; treats $742.50 as a re-entry trigger, not a stop, and would hedge the residual with puts or a collar near $640.
Agrees the near-term tape has rolled over — below 10 EMA/VWMA, negative MACD histogram, deteriorating margins and FCF — but calls a 28% probability of $640 a one-in-four outcome, not a reason to sell half a position in a confirmed long-term uptrend.
Proposes trimming roughly a third (benchmark 3–4% down to ~2.5–3%), reframing $742.50 as a buy-back trigger rather than a hard stop, trimming further only on a confirmed break of $713, and using a $700/$640 put spread (financed by selling $760–780 calls) on the residual.
Does not dispute the bear's numbers but argues a fresh golden cross, a rising 200 SMA, 28% revenue growth and a PEG below 1 describe a confirmed uptrend experiencing a shallow, volume-declining digestion — not a reversal that justifies cutting a core position in half.
Recommends trimming only the shares added above $770, keeping a structure-based stop (e.g., ~$700, below the $713 support) rather than the tight $742.50 level (just 1.1× ATR), and using a collar near $640 for tail protection instead of selling into strength.
Thesis: The bear side wins this debate on delivered evidence, not the bull's forward hopes. Operating income fell 8.2% YoY while revenue grew 28%, operating margin compressed ~12 points to a 30.9% trough, EPS fell 13.4%, Q2 FCF was just $1.7B against $49.1B of H1 capex and $13.7B of SBC, buybacks are paused, and total debt tripled from ~$37B to ~$112B. The bull's best numbers — 28% revenue growth, ~81% gross margin, $115B+ of OCF, a PEG of 0.98 — prove business quality, but the PEG's "G" is forward hope rather than delivered earnings. The tape confirms the near-term risk: META closed below both the 10 EMA and VWMA, sitting on the Bollinger middle band, with a negative MACD histogram, and the Oct 5–6 golden cross is a lagging receipt ~92 sessions into a 50% move. Prediction markets sharpen the skew: 28% odds of touching $640 in October versus 8% for $860. This is a valuation-and-execution problem, not a business-quality problem.
Action: trim META into the current $716–719 zone to roughly half of a standard sector weight (e.g., a 3–4% benchmark weight cut to ~1.5–2%), prioritizing any lots added into the September $770+ rally; do not add at $718.67. Manage the residual by levels rather than a tight stop — a decisive break of $713 support means cutting another tranche into any $700–705 bounce, while a high-volume reclaim and hold above the VWMA ($739.44) and the $741.90 swing high is the signal to buy back trimmed shares. The $640 zone (28% October touch odds) is the pre-identified re-entry if ad growth and capex discipline remain intact; hedge the residual with October puts or a $700/$640 put spread, optionally financed by writing $760–780 calls. Time horizon: through the late-October Q3 print (~4–8 weeks). Watch the Hunterbrook/Muse data flow, Google's frontier-model positioning, and the 96%-priced no-cuts Fed path as the standing overhangs; a high-volume reclaim and hold of $739–742.50, or Q3 evidence of margin stabilization and restored EPS growth, would justify stepping back toward benchmark.